Search Results 331-340 of 16388 for infliximab
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Cemiplimab-rwlc injection is used to treat a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread (metastatic) or cannot be cured ...
Your doctor will test for the presence of this tumor. This medicine is also used alone to treat ESCC that has spread of cannot be removed by surgery in patients ...
Moxetumomab pasudotox-tdfk injection is used to treat hairy cell leukemia that has worsened or cannot be completely removed in patients who have had at least ...
Methotrexate injection is used in combination with other cancer medicines to treat acute lymphoblastic leukemia (ALL), breast cancer, and osteosarcoma (bone ...
(e.g., infliximab, adalimumab), and eosinophil-depleting drugs (e.g., benralizumab, pramipexole); (ii) routine (daily or every other day during 5 or more ...
Infliximab; Ixekizumab; Lebrikizumab-lbkz; Leflunomide; Leniolisib; Lovotibeglogene Autotemcel. Show More. Receiving this vaccine with any of the following ...
Infliximab; Ixekizumab; Lebrikizumab-lbkz; Leflunomide; Leniolisib; Lovotibeglogene Autotemcel; Mirikizumab-mrkz; Mycophenolate Mofetil. Show More. Receiving ...
This phase I trial studies the side effects and the best dose of pazopanib hydrochloride in treating patients with solid tumors that has spread to other places ...
The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!